|
Industry: Healthcare Industry
|
|
|
| Overview of the clinical significance and market needs for both current and emerging tumor markers. Extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications. |
|
|
| Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact |
|
|
| Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact d |
|
|
| Major issues pertaining to the French transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. |
|
|
| Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during t |
|
|
| Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact |
|
|
| Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. |
|
|
| Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during t |
|
|
| This 360-page report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. |
|
|
| Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. |
|
Company Reports
US Office
India Office